Cross-clade immune responses reported in South African RV144 HIV vaccine regimen
(PHYSorg.com Medicine & Health)

Despite major breakthroughs in HIV prevention and treatment, there were an estimated 1.8 million people newly infected with HIV in 2018, and an estimated 5,000 new HIV infections around the world every day. The pursuit for a safe, effective and scalable HIV vaccine, although a challenging endeavor, is a global imperative.